![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnY1kUf2R9vdE5sM-lVBCcRMm-ozrAaplVuq4DIyv4ry2w7xQ65ZcUl3U99coTOEx2tVUI8DFNYbsOXk60UYzbtddQInPpb3iUTZMzw3XKpq1b82dIZ4tftzfvdBAdXC2Zxqmf1WwHhGjz/s320/mickeykim.jpg)
Mickey Kim will from Canaan's Westport, Conn. office. He joined the firm in July according to his bio.
Mickey joined Canaan from Pacific Point Ventures, a venture capital fund investing in healthcare infrastructure companies in Asia. Prior to co-founding Pacific Point Ventures, he invested in biotech and medical device companies at BioVentures Investors, including ActivBiotics, Applied Spine Technologies, Cylene Pharmaceuticals, Hydra Biosciences and Sciona. Mickey also served as a strategy consultant at McKinsey & Company and CSC Healthcare, and co-founded an Asian technology venture capital fund.
Canaan doesn't appear to have any health care portfolio companies in Asia at this point. It does have two IT-oriented deals in India.
No doubt there will be more news like this to come.
No comments:
Post a Comment